Ladenburg Thalmann Financial Services’s Nymox Pharmaceutical Corp NYMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $11K | Buy |
5,000
+500
| +11% | +$1.1K | ﹤0.01% | 4463 |
|
|
2019
Q3 | $8K | Hold |
4,500
| – | – | ﹤0.01% | 4510 |
|
|
2019
Q2 | $7K | Sell |
4,500
-500
| -10% | -$778 | ﹤0.01% | 4601 |
|
|
2019
Q1 | $10K | Sell |
5,000
-1,600
| -24% | -$3.2K | ﹤0.01% | 4388 |
|
|
2018
Q4 | $9K | Buy |
6,600
+500
| +8% | +$682 | ﹤0.01% | 4361 |
|
|
2018
Q3 | $15K | Sell |
6,100
-500
| -8% | -$1.23K | ﹤0.01% | 4079 |
|
|
2018
Q2 | $28K | Hold |
6,600
| – | – | ﹤0.01% | 3645 |
|
|
2018
Q1 | $28K | Hold |
6,600
| – | – | ﹤0.01% | 3645 |
|
|
2017
Q4 | $22K | Sell |
6,600
-500
| -7% | -$1.67K | ﹤0.01% | 3742 |
|
|
2017
Q3 | $27K | Hold |
7,100
| – | – | ﹤0.01% | 3512 |
|
|
2017
Q2 | $31K | Hold |
7,100
| – | – | ﹤0.01% | 3343 |
|
|
2017
Q1 | $26K | Hold |
7,100
| – | – | ﹤0.01% | 3391 |
|
|
2016
Q4 | $19K | Sell |
7,100
-500
| -7% | -$1.34K | ﹤0.01% | 3523 |
|
|
2016
Q3 | $25K | Hold |
7,600
| – | – | ﹤0.01% | 3258 |
|
|
2016
Q2 | $25K | Sell |
7,600
-1,400
| -16% | -$4.61K | ﹤0.01% | 3200 |
|
|
2016
Q1 | $22K | Sell |
9,000
-500
| -5% | -$1.22K | ﹤0.01% | 3192 |
|
|
2015
Q4 | $31K | Sell |
9,500
-500
| -5% | -$1.63K | ﹤0.01% | 2924 |
|
|
2015
Q3 | $34K | Sell |
10,000
-130
| -1% | -$442 | ﹤0.01% | 2743 |
|
|
2015
Q2 | $13K | Hold |
10,130
| – | – | ﹤0.01% | 3528 |
|
|
2015
Q1 | $8K | Sell |
10,130
-500
| -5% | -$395 | ﹤0.01% | 3775 |
|
|
2014
Q4 | $4K | Sell |
10,630
-770
| -7% | -$290 | ﹤0.01% | 3846 |
|
|
2014
Q3 | $50K | Hold |
11,400
| – | – | ﹤0.01% | 2032 |
|
|
2014
Q2 | $56K | Sell |
11,400
-1,000
| -8% | -$4.91K | ﹤0.01% | 1977 |
|
|
2014
Q1 | $68K | Hold |
12,400
| – | – | ﹤0.01% | 1748 |
|
|
2013
Q4 | $75K | Hold |
12,400
| – | – | ﹤0.01% | 1649 |
|
|
2013
Q3 | $82K | Buy |
+12,400
| New | +$82K | ﹤0.01% | 1503 |
|